![](http://expogr.com/news_images/68290.jpg)
The Kenyan Government and Moderna (Mrna) Have Finalised Their Agreement to Establish an MRNA Manufacturing Facility
A facility to provide Kenya and the African continent with access to manufactured mRNA vaccines, ensuring health security and advancing Moderna's commitments to global public health. Up to 500 million doses can be produced annually at the facility. An agreement to establish an mRNA manufacturing facility in the Republic of Kenya has been finalised by Moderna, Inc. (NASDAQ: MRNA) and the Government of the Republic of Kenya. The.... Read more »
Posted on : Friday , 28th April 2023